skip to main content

DOE PAGESDOE PAGES

Title: Non-catalytic Roles for XPG with BRCA1 and BRCA2 in Homologous Recombination and Genome Stability

XPG is a structure-specific endonuclease required for nucleotide excision repair, and incision-defective XPG mutations cause the skin cancer-prone syndrome xeroderma pigmentosum. Truncating mutations instead cause the neurodevelopmental progeroid disorder Cockayne syndrome, but little is known about how XPG loss results in this devastating disease. In this paper, we identify XPG as a partner of BRCA1 and BRCA2 in maintaining genomic stability through homologous recombination (HRR). XPG depletion causes DNA double-strand breaks, chromosomal abnormalities, cell-cycle delays, defective HRR, inability to overcome replication fork stalling, and replication stress. XPG directly interacts with BRCA2, RAD51, and PALB2, and XPG depletion reduces their chromatin binding and subsequent RAD51 foci formation. Upstream in HRR, XPG interacts directly with BRCA1. Its depletion causes BRCA1 hyper-phosphorylation and persistent chromatin binding. Finally, these unexpected findings establish XPG as an HRR protein with important roles in genome stability and suggest how XPG defects produce severe clinical consequences including cancer and accelerated aging.
Authors:
 [1] ;  [1] ;  [2] ;  [1] ;  [3] ;  [1] ;  [1] ;  [1] ;  [1] ;  [1] ;  [1] ;  [4] ;  [3] ;  [1] ;  [5] ;  [1]
  1. Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
  2. Buck Inst. for Research on Aging, Novato, CA (United States)
  3. Yale Univ., New Haven, CT (United States). School of Medicine
  4. Erasmus Univ. Medical Center, Rotterdam (Netherlands)
  5. Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States); Buck Inst. for Research on Aging, Novato, CA (United States)
Publication Date:
Grant/Contract Number:
AC02-05CH11231; R01 ES019935; P01 CA092584; R21 CA187765; P01 AG017242; R01 ES015252; R01 ES021454
Type:
Published Article
Journal Name:
Molecular Cell
Additional Journal Information:
Journal Volume: 61; Journal Issue: 4; Journal ID: ISSN 1097-2765
Publisher:
Elsevier - Cell Press
Research Org:
Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
Sponsoring Org:
USDOE Office of Science (SC); National Inst. of Health (NIH) (United States)
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES
OSTI Identifier:
1344183
Alternate Identifier(s):
OSTI ID: 1379099

Trego, Kelly S., Groesser, Torsten, Davalos, Albert R., Parplys, Ann C., Zhao, Weixing, Nelson, Michael R., Hlaing, Ayesu, Shih, Brian, Rydberg, Björn, Pluth, Janice M., Tsai, Miaw-Sheue, Hoeijmakers, Jan H. J., Sung, Patrick, Wiese, Claudia, Campisi, Judith, and Cooper, Priscilla K.. Non-catalytic Roles for XPG with BRCA1 and BRCA2 in Homologous Recombination and Genome Stability. United States: N. p., Web. doi:10.1016/j.molcel.2015.12.026.
Trego, Kelly S., Groesser, Torsten, Davalos, Albert R., Parplys, Ann C., Zhao, Weixing, Nelson, Michael R., Hlaing, Ayesu, Shih, Brian, Rydberg, Björn, Pluth, Janice M., Tsai, Miaw-Sheue, Hoeijmakers, Jan H. J., Sung, Patrick, Wiese, Claudia, Campisi, Judith, & Cooper, Priscilla K.. Non-catalytic Roles for XPG with BRCA1 and BRCA2 in Homologous Recombination and Genome Stability. United States. doi:10.1016/j.molcel.2015.12.026.
Trego, Kelly S., Groesser, Torsten, Davalos, Albert R., Parplys, Ann C., Zhao, Weixing, Nelson, Michael R., Hlaing, Ayesu, Shih, Brian, Rydberg, Björn, Pluth, Janice M., Tsai, Miaw-Sheue, Hoeijmakers, Jan H. J., Sung, Patrick, Wiese, Claudia, Campisi, Judith, and Cooper, Priscilla K.. 2016. "Non-catalytic Roles for XPG with BRCA1 and BRCA2 in Homologous Recombination and Genome Stability". United States. doi:10.1016/j.molcel.2015.12.026.
@article{osti_1344183,
title = {Non-catalytic Roles for XPG with BRCA1 and BRCA2 in Homologous Recombination and Genome Stability},
author = {Trego, Kelly S. and Groesser, Torsten and Davalos, Albert R. and Parplys, Ann C. and Zhao, Weixing and Nelson, Michael R. and Hlaing, Ayesu and Shih, Brian and Rydberg, Björn and Pluth, Janice M. and Tsai, Miaw-Sheue and Hoeijmakers, Jan H. J. and Sung, Patrick and Wiese, Claudia and Campisi, Judith and Cooper, Priscilla K.},
abstractNote = {XPG is a structure-specific endonuclease required for nucleotide excision repair, and incision-defective XPG mutations cause the skin cancer-prone syndrome xeroderma pigmentosum. Truncating mutations instead cause the neurodevelopmental progeroid disorder Cockayne syndrome, but little is known about how XPG loss results in this devastating disease. In this paper, we identify XPG as a partner of BRCA1 and BRCA2 in maintaining genomic stability through homologous recombination (HRR). XPG depletion causes DNA double-strand breaks, chromosomal abnormalities, cell-cycle delays, defective HRR, inability to overcome replication fork stalling, and replication stress. XPG directly interacts with BRCA2, RAD51, and PALB2, and XPG depletion reduces their chromatin binding and subsequent RAD51 foci formation. Upstream in HRR, XPG interacts directly with BRCA1. Its depletion causes BRCA1 hyper-phosphorylation and persistent chromatin binding. Finally, these unexpected findings establish XPG as an HRR protein with important roles in genome stability and suggest how XPG defects produce severe clinical consequences including cancer and accelerated aging.},
doi = {10.1016/j.molcel.2015.12.026},
journal = {Molecular Cell},
number = 4,
volume = 61,
place = {United States},
year = {2016},
month = {1}
}